Crocs set to join s&p midcap 400 and organogenesis to join s&p smallcap 600

New york, may 26, 2021 /prnewswire/ -- s&p smallcap 600 constituent crocs inc. (nasd:crox) will replace cantel medical corp. (nyse:cmd) in the s&p midcap 400, and organogenesis holdings inc. (nasd: orgo) will replace crocs in the s&p smallcap 600 effective prior to the opening of trading on wednesday, june 2, 2021. steris plc (nyse: ste) is acquiring cantel medical in a deal expected to be completed soon pending final closing conditions.
SPGI Ratings Summary
SPGI Quant Ranking